Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer.
Saved in:
| Title: | Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer. |
|---|---|
| Authors: | Wu, Y (AUTHOR), Amonkar, M M (AUTHOR), Sherrill, B H (AUTHOR), O'Shaughnessy, J (AUTHOR), Ellis, C (AUTHOR), Baselga, J (AUTHOR), Blackwell, K L (AUTHOR), Burstein, H J (AUTHOR) |
| Source: | Annals of Oncology. Jun2019, Vol. 30 Issue 6, p1019-1019. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdy531 |
